Veloxis Pharmaceuticals A/S
Warrant Programme – New Articles of Association
DGAP-News: Veloxis Pharmaceuticals A/S 2015-03-03 / 19:34 --------------------------------------------------------------------- Company Announcement no. 6/2015 To: NASDAQ OMX Copenhagen A/S Hørsholm, Denmark, 3 March 2015 Warrant Programme - New Articles of Association In accordance with its authorisation pursuant to Section 5A of the Articles of Association, the Board of Directors of Veloxis Pharmaceuticals A/S has on 3 March 2015 issued 23,700,842 warrants for the subscription of nominally DKK 2,370,084.20 shares in the Company. The amendment of the Articles of Association associated with the issue of warrants has today been registered with the Danish Business Authority. The new Articles of Association are for Veloxis Pharmaceuticals A/S are attached. For more information, please contact: Veloxis Pharmaceuticals A/S Bill Polvino Johnny Stilou President & CEO EVP, Chief Financial Officer Phone: +1 732 321 3202 Phone: +45 30 53 33 64 Email: wjp@veloxis.com Email: jst@veloxis.com About Veloxis Pharmaceuticals Based in Hørsholm, Denmark, with an office in New Jersey, Veloxis Pharmaceuticals A/S, or Veloxis, is a specialty pharmaceutical company. Veloxis' unique, patented delivery technology, MeltDose(R), is designed to enhance the absorption and bioavailability of select orally administered drugs. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO. For further information, please visit www.veloxis.com. News Source: NASDAQ OMX --------------------------------------------------------------------- 2015-03-03 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Veloxis Pharmaceuticals A/S Denmark ISIN: DK0060048148 End of News DGAP News-Service --------------------------------------------------------------------- 329449 2015-03-03
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden